JORDYN DALBY: Open Payments
NPI 1457828923 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 38 payments from 12 companies in 2025. Trend: 2023 $851 · 2024 $1,777 · 2025 $1,155
Food & beverage: $1,071Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $292 |
| Janssen Biotech, Inc. | 2 | $207 |
| Janssen Scientific Affairs, LLC | 2 | $190 |
| Phathom Pharmaceuticals, Inc. | 6 | $160 |
| Lilly USA, LLC | 1 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| GENZYME CORPORATION | 2 | $42 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, OMVOH, ENTYVIO, DUPIXENT, SKYRIZI, LINZESS.
Industry payments across TX — which companies pay providers there.
